Advertisement
Screener

VERU INC. (VERU) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • VERU INC. return tang equity for the quarter ending 2026-06-30 was -69.27%, a change of 425.32% year-over-year.
  • VERU INC. return tang equity for the quarter ending 2026-03-31 was -53.55%, a change of 241.56% year-over-year.
  • VERU INC. return tang equity for the quarter ending 2025-12-31 was -67.32%, a change of 147.65% year-over-year.
  • VERU INC. return tang equity for the quarter ending 2025-09-30 was -236.69%, a change of -76.42% year-over-year.
  • VERU INC. return tang equity for fiscal 2025 was -236.69%, a change of -76.42% from fiscal 2024.
  • VERU INC. return tang equity for fiscal 2024 was -160.27%, a change of 690.66% from fiscal 2023.
  • VERU INC. return tang equity for fiscal 2023 was -850.93%, a change of -737.47% from fiscal 2022.
  • VERU INC. return tang equity for fiscal 2022 was -113.47%, a 2337.09% decline from fiscal 2021.
Available history
2009-09-30 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-69.27%-$13.61M$19.65M
2026-03-31-53.55%-$13.95M$26.05M
2025-12-31-67.32%-$19.11M$28.39M
2025-09-30-236.69%-$22.73M$9.6M
2025-06-30-494.60%-$32.71M$6.61M
2025-03-31-295.11%-$36.35M$12.32M
2024-12-31-214.97%-$38.47M$17.9M
2024-09-30-160.27%-$37.8M$23.59M
2024-06-30-129.47%-$37.4M$28.89M
2024-03-31-106.79%-$38.96M$36.48M
2023-12-31-146.37%-$62.72M$42.85M
2023-09-30-850.93%-$93.15M$10.95M
2023-06-30-1060.06%-$126.31M$11.92M
2023-03-31-1039.55%-$135.98M$13.08M
2022-12-31-287.62%-$116.37M$40.46M
2022-09-30-113.47%-$84.04M$74.07M
2022-06-30-43.51%-$47.05M$108.14M
2022-03-31-21.64%-$27.55M$127.27M
2021-12-31-11.64%-$16.21M$139.27M
2021-09-305.07%$7.39M$145.79M
2021-06-30-0.10%-$143,691.00$146.24M
2021-03-31-0.32%-$476,205.00$146.76M
2020-12-313.90%$1.56M$40.02M
2020-09-30-88.74%-$18.97M$21.38M
2020-06-30-31.42%-$10.2M$32.47M
2020-03-31-44.77%-$9.95M$22.23M
2019-12-31-63.72%-$13.17M$20.67M
2019-09-30-51.61%-$12.02M$23.29M
2019-06-30-65.89%-$16.88M$25.61M
2019-03-31-90.51%-$22.03M$24.34M
2018-12-31-79.09%-$21.83M$27.6M
2018-09-30-118.95%-$23.94M$20.12M
2018-06-30-70.71%-$18.7M$26.44M
2018-03-31-36.30%-$11.56M$31.84M
2017-12-31-27.01%-$9.5M$35.19M
2017-09-30-17.03%-$6.61M$38.82M
2017-06-30-24.56%-$5.68M$23.14M
2017-03-31-18.15%-$4.32M$23.82M
2016-12-31-9.85%-$2.51M$25.49M
2016-09-301.02%$344,725.00$33.93M
2016-06-307.88%$2.8M$35.51M
2016-03-319.75%$3.4M$34.85M
2015-12-3114.49%$5.03M$34.72M
2015-09-3013.12%$4.35M$33.13M
2015-06-309.51%$3.08M$32.38M
2015-03-319.87%$3.07M$31.06M
2014-12-316.06%$1.77M$29.26M
2014-09-308.67%$2.43M$28.07M
2014-06-3033.10%$9.59M$28.97M
2014-03-3133.00%$9.16M$27.75M
2013-12-3141.93%$12.27M$29.27M
2013-09-3045.67%$14.34M$31.4M
2013-06-3059.62%$15.94M$26.73M
2013-03-3168.61%$17.76M$25.89M
2012-12-3166.06%$16.17M$24.48M
2012-09-3063.17%$15.3M$24.22M
2012-06-3058.19%$11.63M$19.99M
2012-03-3154.75%$9.5M$17.34M
2011-12-3145.25%$7.67M$16.96M
2011-09-3032.23%$5.4M$16.75M
2011-06-3047.55%$6.4M$13.46M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-09-30-236.69%-$22.73M$9.6M
2024-09-30-160.27%-$37.8M$23.59M
2023-09-30-850.93%-$93.15M$10.95M
2022-09-30-113.47%-$84.04M$74.07M
2021-09-305.07%$7.39M$145.79M
2020-09-30-88.74%-$18.97M$21.38M
2019-09-30-51.61%-$12.02M$23.29M
2018-09-30-118.95%-$23.94M$20.12M
2017-09-30-17.03%-$6.61M$38.82M
2016-09-301.02%$344,725.00$33.93M
2015-09-3013.12%$4.35M$33.13M
2014-09-308.67%$2.43M$28.07M
2013-09-3045.67%$14.34M$31.4M
2012-09-3063.17%$15.3M$24.22M
2011-09-3032.23%$5.4M$16.75M
2010-09-3041.76%$6.74M$16.13M
2009-09-3050.45%$6.54M$12.95M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34